Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	55.52	14.86	9.56
Graham Fair Price	-0.76	65173.67	65674.79
PEG	12668.31	-0.59	< 0.005
Price/Book	-1.31	0.16	0.16
Price/Cash Flow	111.56	4.42	2.09
Prices/Earnings	3.18	1.72	1.67
Price/Sales	0.43	0.16	0.16
Price/FCF	111.56	4.42	2.09
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.71	0.08	0.08
Operating Margin	-42.99	0.04	0.07
ROA	-7.09	< 0.005	< 0.005
ROE	0.02	0.02	-4.35
ROIC	0.03	0.02	-46.98
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	< 0.005	872.92
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.08	-0.43	-86.00
EPS QOQ	3.65	-0.03	-99.19
FCF QOQ	1.49	-0.53	-64.62
Revenue QOQ	0.10	< 0.005	-97.24
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	66.59	51.61	-22.49
Days Sales Outstanding (DSO)	65.33	72.34	10.73
Inventory Turnover	1.35	1.74	29.02
Debt/Capitalization	0.49	0.51	4.33
Quick Ratio	0.66	0.73	10.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	90108.27	91431.81	1.47
Cash	38075.84	48991.04	28.67
Capex	-1232.39	-1133.40	8.03
Free Cash Flow	6804.95	3221.07	-52.67
Revenue	90951.48	90693.06	-0.28
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.31	1.32	0.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.70	11.82	53.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating